Active — Not RecruitingNot Applicable

Long-Term Follow-Up of Patients Who Have Participated in Children's Oncology Group Studies

United States5,000 participantsStarted 2008-07-17

Plain-language summary

This clinical trial keeps track of and collects follow-up information from patients who are currently enrolled on or have participated in a Children's Oncology Group study. Developing a way to keep track of patients who have participated in Children's Oncology Group studies may allow doctors learn more about the long-term effects of cancer treatment and help them reduce problems related to treatment and improve patient quality of life.

Who can participate

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * The patient must reside in the U.S. on the date of enrollment to ALTE05N1 * All patients and/or their parents or legal guardians must sign a written informed consent * All institutional, Food and Drug Administration (FDA), and National Cancer Institute (NCI) requirements for human studies must be met

What they're measuring

Percentage of patients enrolled

Timeframe: Up to 20 years

Percentage of patients in which long-term (20+ years) contact is maintained

Timeframe: Up to 20 years

Percentage of eligible patients located who were lost to follow-up

Timeframe: Up to 20 years

Percentage of located patients enrolled

Timeframe: Up to 20 years

Collection of protocol-specific outcome data

Timeframe: Up to 20 years

Collection of cumulative therapeutic exposure data

Timeframe: Up to 20 years

Trial details

NCT IDNCT00736749

SponsorChildren's Oncology Group

Sponsor typeNETWORK

Study typeOBSERVATIONAL

Primary completion2100-01-31

View on ClinicalTrials.gov More Hematopoietic Cell Transplantation Recipient trials